Insights

Distribution partnerships Leverage recent channel partnerships with Buy-Supply Corp and NISSCO to introduce Novalent antimicrobial coatings to a broader customer base across multiple industries and geographies.

Brand credibility Highlight proven adoption by major US brands such as PepsiCo, Pilgrims, and HanesBrands to position Novalent as a trusted partner for large enterprises seeking long-lasting germ protection solutions.

Strategic advisory Engage the advisory network, including academia or industry thought leaders like Harvard Business School connections, to co-market to enterprise clients and refine value propositions for sustainability-conscious buyers.

Health and safety differentiation Position the 90-day surface protection and 24-hour skin protection as a distinctive, high-efficacy sanitation solution for facilities, healthcare, food processing, and consumer goods manufacturers seeking reduced cleaning cycles and improved safety metrics.

Financial momentum Target mid-market and enterprise prospects with scale-up needs, leveraging the $11M funding history and current revenue range to discuss growth partnerships, deployment at scale, and favorable ROI from long-lasting antimicrobial technology.

Similar companies to Novālent Ltd.

Novālent Ltd. Tech Stack

Novālent Ltd. uses 8 technology products and services including Unpkg, Slick, jQuery, and more. Explore Novālent Ltd.'s tech stack below.

  • Unpkg
    Content Delivery Network
  • Slick
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • WP Engine
    Platform As A Service
  • X-XSS-Protection
    Security
  • HTTP/3
    Web & Portal Technology
  • Adobe Fonts
    Web Fonts
  • prettyPhoto
    Web Tools And Plugins

Novālent Ltd.'s Email Address Formats

Novālent Ltd. uses at least 1 format(s):
Novālent Ltd. Email FormatsExamplePercentage
First.Last@novalent.comJohn.Doe@novalent.com
100%

Frequently Asked Questions

What is Novālent Ltd.'s official website and social media links?

Minus sign iconPlus sign icon
Novālent Ltd.'s official website is novalent.com and has social profiles on LinkedInCrunchbase.

How much revenue does Novālent Ltd. generate?

Minus sign iconPlus sign icon
As of July 2026, Novālent Ltd.'s annual revenue is estimated to be $1M - $10M.

What is Novālent Ltd.'s NAICS code?

Minus sign iconPlus sign icon
Novālent Ltd.'s NAICS code is 325 - Chemical Manufacturing.

How many employees does Novālent Ltd. have currently?

Minus sign iconPlus sign icon
As of July 2026, Novālent Ltd. has approximately 8 employees across 3 continents, including North AmericaEuropeOceania. Key team members include Vice President , Sales: B. M.Key Account Manager: B. K.Serviceingenjör/Sälj: L. A.. Explore Novālent Ltd.'s employee directory with LeadIQ.

What industry does Novālent Ltd. belong to?

Minus sign iconPlus sign icon
Novālent Ltd. operates in the Chemical Manufacturing industry.

What technology does Novālent Ltd. use?

Minus sign iconPlus sign icon
Novālent Ltd.'s tech stack includes UnpkgSlickjQueryWP EngineX-XSS-ProtectionHTTP/3Adobe FontsprettyPhoto.

What is Novālent Ltd.'s email format?

Minus sign iconPlus sign icon
Novālent Ltd.'s email format typically follows the pattern of First.Last@novalent.com. Find more Novālent Ltd. email formats with LeadIQ.

How much funding has Novālent Ltd. raised to date?

Minus sign iconPlus sign icon
As of July 2026, Novālent Ltd. has raised $11M in funding. The last funding round occurred on Nov 30, 2021 for $11M.
Novālent Ltd. logo

Novālent Ltd.

Chemical ManufacturingNorth Carolina, United States2-10 Employees

Novālent Ltd. is a Greensboro, North Carolina-based chemical manufacturing and biotechnology engineering firm focused on surface- and skin-facing antimicrobial protection. Its technology uses a patented, non-toxic monomolecular layer that can continuously kill germs on surfaces for up to 90 days and on human skin for up to 24 hours after application, offering ongoing sanitization without frequent reapplication. The company serves a corporate customer base, including brands like PepsiCo, Pilgrims, and HanesBrands, and has established distribution and partnerships to reach multiple channels. Novālent operates within the US biotechnology engineering sector and positions itself as an innovator providing long-lasting antimicrobial solutions for commercial use. In recent developments, the firm announced partnerships to broaden its distribution network and channel reach.

Section iconCompany Overview

NAICS Code
325 - Chemical Manufacturing
Employees
2-10

Section iconFunding & Financials

  • $11M

    Novālent Ltd. has raised a total of $11M of funding over 1 rounds. Their latest funding round was raised on Nov 30, 2021 in the amount of $11Mas a undisclosed.

  • $1M - $10M

    Novālent Ltd.'s revenue is estimated to be in the range of $1M - $10M

Section iconFunding & Financials

  • $11M

    Novālent Ltd. has raised a total of $11M of funding over 1 rounds. Their latest funding round was raised on Nov 30, 2021 in the amount of $11Mas a undisclosed.

  • $1M - $10M

    Novālent Ltd.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.